Search Result

No matches for "

51307

" within the MedChemExpress (MCE) catalog. Here are the results you might be looking for.

By Targets:	Bacterial (7) Beta-lactamase (3) Calcium Channel (1) Epigenetic Reader Domain (1) MicroRNA (20) PD-1/PD-L1 (1) Penicillin-binding protein (PBP) (3) Reference Standards (1) TNF Receptor (1) Transmembrane Glycoprotein (1)
By Research Areas:	Cancer (24) Infection (7) Inflammation/Immunology (3) Neurological Disease (1)
Oligonucleotides:	miRNA mimics (5) miRNA agomirs (5) miRNA antagomirs (5) MicroRNAs (20) miRNA inhibitors (5)

Inhibitors & Agonists

Inhibitory Antibodies

Recombinant Proteins

Antibodies

Oligonucleotides

Cat. No.	Product Name	Target	Research Areas	Chemical Structure

HY-120859

Zidebactam Maximum Cited Publications 10 Publications Verification WCK-5107	Beta-lactamase Penicillin-binding protein (PBP) Bacterial	Infection
Zidebactam (WCK-5107) is a potent β-lactamase inhibitor . Zidebactam also is a penicillin-binding protein2 (PBP2) inhibitor with an IC₅₀ of 0.26 μg/mL .

HY-111422

PLX51107 3 Publications Verification	Epigenetic Reader Domain	Cancer
PLX51107 is a potent and selective BET inhibitor, with K_ds of 1.6, 2.1, 1.7, and 5 nM for BD1 and 5.9, 6.2, 6.1, and 120 nM for BD2 of BRD2, BRD3, BRD4, and BRDT, respectively; PLX51107 also interacts with the bromodomains of CBP and EP300 (K_d, in the 100 nM range).

HY-147045

UCB-5307	TNF Receptor	Inflammation/Immunology
UCB-5307 is a potent TNF signaling inhibitor with a K_D of 9 nM for human TNFα. UCB-5307 can penetrate the preformed hTNF/hTNFR1 complex .

HY-W028047

JFD01307SC	Bacterial	Infection Inflammation/Immunology
JFD01307SC is a glutamine synthetase inhibitor and anti-tuberculosis agent. JFD01307SC acts as a mimic of L-Glutamate and thus target enzymes involved in glutamine biosynthesis .

HY-161135A

(rac)-TBAJ-5307	Bacterial	Infection
(rac)-TBAJ-5307 is the racemate of TBAJ-5307 (HY-161135). TBAJ-5307 is a broad spectrum anti-non-tuberculous mycobacteria inhibitor that can target the FO-domain of the engine and preventing rotation and proton-translocation .

HY-120859A

Zidebactam sodium salt WCK-5107 sodium salt	Beta-lactamase Penicillin-binding protein (PBP) Bacterial	Infection
Zidebactam sodium salt (WCK-5107 sodium salt) is a potent β-lactamase inhibitor . Zidebactam also is a penicillin-binding protein2 (PBP2) inhibitor with an IC₅₀ of 0.26 μg/mL .

HY-132212

LH1307	PD-1/PD-L1	Inflammation/Immunology Cancer
LH1307 is a C2-symmetric inhibitor of PD-1/PD-L1 protein-protein interactions with a IC₅₀ value of 3.0 μM and can be used in cancer studies .

HY-161135

TBAJ-5307	Bacterial	Infection
TBAJ-5307 is a broad spectrum anti-non-tuberculous mycobacteria inhibitor that can target the FO-domain of the engine and preventing rotation and proton-translocation. TBAJ-5307 inhibits non-tuberculous mycobacteria in vitro and in vivo .

HY-120859R

Zidebactam (Standard) WCK-5107 (Standard)	Beta-lactamase Penicillin-binding protein (PBP) Bacterial Reference Standards	Infection
Zidebactam (Standard) is the analytical standard of Zidebactam. This product is intended for research and analytical applications. Zidebactam (WCK-5107) is a potent β-lactamase inhibitor . Zidebactam also is a penicillin-binding protein2 (PBP2) inhibitor with an IC50 of 0.26 μg/mL .

HY-100289

MF 5137	Bacterial	Infection
MF 5137 is a potent antibacterial agent.

HY-118974

PD-151307	Calcium Channel	Neurological Disease Cancer
PD-151307 is an N-type calcium channel antagonist with significant inhibitory effects in IMR-32 human neuroblastoma cells, exhibiting an IC₅₀ of 0.32 µM. PD-151307 can be used in research related to cancer therapy, anticonvulsants, and neuropathic pain .

HY-R03276

*mmu-miR-5130* mimic**	MicroRNA	Cancer
mmu-miR-5130 mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.

mmu-miR-5130 mimic mmu-miR-5130 mimic

HY-P991387

AGEN1307 AGEN1327	Transmembrane Glycoprotein	Cancer
AGEN1307 is a human monoclonal antibody (mAb) targeting TIGIT. AGEN1307 has an active FcγR binding region and enhances antibody-dependent cellular cytotoxicity (ADCC). AGEN1307 can be used in cancer research .

HY-R00240

*hsa-miR-1307-5p mimic*	MicroRNA	Cancer
hsa-miR-1307-5p mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.

hsa-miR-1307-5p mimic hsa-miR-1307-5p mimic

HY-R03252

*mmu-miR-5107-3p mimic*	MicroRNA	Cancer
mmu-miR-5107-3p mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.

mmu-miR-5107-3p mimic mmu-miR-5107-3p mimic

HY-R00239

*hsa-miR-1307-3p mimic*	MicroRNA	Cancer
hsa-miR-1307-3p mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.

hsa-miR-1307-3p mimic hsa-miR-1307-3p mimic

HY-RI00239A

*hsa-miR-1307-3p antagomir*	MicroRNA	Cancer
hsa-miR-1307-3p antagomirs are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA antagomirs have 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 1 cholesterol group at the 3' end, and full-length nucleotide 2'-methoxy modification. The miRNA antagomirs strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning. Stability of miRNA antagomirs appears to be significantly higher than miRNA inhibitors, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.

hsa-miR-1307-3p antagomir hsa-miR-1307-3p antagomir

HY-R03253

*mmu-miR-5107-5p mimic*	MicroRNA	Cancer
mmu-miR-5107-5p mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.

mmu-miR-5107-5p mimic mmu-miR-5107-5p mimic

HY-RI03276A

*mmu-miR-5130* antagomir**	MicroRNA	Cancer
mmu-miR-5130 antagomirs are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA antagomirs have 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 1 cholesterol group at the 3' end, and full-length nucleotide 2'-methoxy modification. The miRNA antagomirs strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning. Stability of miRNA antagomirs appears to be significantly higher than miRNA inhibitors, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.

mmu-miR-5130 antagomir mmu-miR-5130 antagomir

HY-RI03276

*mmu-miR-5130* inhibitor**	MicroRNA	Cancer
mmu-miR-5130 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

mmu-miR-5130 inhibitor mmu-miR-5130 inhibitor

HY-R03276A

*mmu-miR-5130* agomir**	MicroRNA	Cancer
mmu-miR-5130 agomirs are chemically-modified double-strand miRNA mimics with modified mature miRNA strand: 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 3' end cholesterol group, and full-length nucleotide 2'-methoxy modification. They are designed to mimic endogenous miRNAs and recommended for miRNA functional studies. Compared with miRNA mimics, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.

mmu-miR-5130 agomir mmu-miR-5130 agomir

HY-RI00240

*hsa-miR-1307-5p inhibitor*	MicroRNA	Cancer
hsa-miR-1307-5p inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

hsa-miR-1307-5p inhibitor hsa-miR-1307-5p inhibitor

HY-R00240A

*hsa-miR-1307-5p agomir*	MicroRNA	Cancer
hsa-miR-1307-5p agomirs are chemically-modified double-strand miRNA mimics with modified mature miRNA strand: 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 3' end cholesterol group, and full-length nucleotide 2'-methoxy modification. They are designed to mimic endogenous miRNAs and recommended for miRNA functional studies. Compared with miRNA mimics, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.

hsa-miR-1307-5p agomir hsa-miR-1307-5p agomir

HY-RI00240A

*hsa-miR-1307-5p antagomir*	MicroRNA	Cancer
hsa-miR-1307-5p antagomirs are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA antagomirs have 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 1 cholesterol group at the 3' end, and full-length nucleotide 2'-methoxy modification. The miRNA antagomirs strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning. Stability of miRNA antagomirs appears to be significantly higher than miRNA inhibitors, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.

hsa-miR-1307-5p antagomir hsa-miR-1307-5p antagomir

HY-RI03253A

*mmu-miR-5107-5p antagomir*	MicroRNA	Cancer
mmu-miR-5107-5p antagomirs are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA antagomirs have 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 1 cholesterol group at the 3' end, and full-length nucleotide 2'-methoxy modification. The miRNA antagomirs strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning. Stability of miRNA antagomirs appears to be significantly higher than miRNA inhibitors, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.

mmu-miR-5107-5p antagomir mmu-miR-5107-5p antagomir

HY-R03252A

*mmu-miR-5107-3p agomir*	MicroRNA	Cancer
mmu-miR-5107-3p agomirs are chemically-modified double-strand miRNA mimics with modified mature miRNA strand: 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 3' end cholesterol group, and full-length nucleotide 2'-methoxy modification. They are designed to mimic endogenous miRNAs and recommended for miRNA functional studies. Compared with miRNA mimics, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.

mmu-miR-5107-3p agomir mmu-miR-5107-3p agomir

HY-RI00239

*hsa-miR-1307-3p inhibitor*	MicroRNA	Cancer
hsa-miR-1307-3p inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

hsa-miR-1307-3p inhibitor hsa-miR-1307-3p inhibitor

HY-R00239A

*hsa-miR-1307-3p agomir*	MicroRNA	Cancer
hsa-miR-1307-3p agomirs are chemically-modified double-strand miRNA mimics with modified mature miRNA strand: 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 3' end cholesterol group, and full-length nucleotide 2'-methoxy modification. They are designed to mimic endogenous miRNAs and recommended for miRNA functional studies. Compared with miRNA mimics, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.

hsa-miR-1307-3p agomir hsa-miR-1307-3p agomir

HY-RI03253

*mmu-miR-5107-5p inhibitor*	MicroRNA	Cancer
mmu-miR-5107-5p inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

mmu-miR-5107-5p inhibitor mmu-miR-5107-5p inhibitor

HY-RI03252A

*mmu-miR-5107-3p antagomir*	MicroRNA	Cancer
mmu-miR-5107-3p antagomirs are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA antagomirs have 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 1 cholesterol group at the 3' end, and full-length nucleotide 2'-methoxy modification. The miRNA antagomirs strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning. Stability of miRNA antagomirs appears to be significantly higher than miRNA inhibitors, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.

mmu-miR-5107-3p antagomir mmu-miR-5107-3p antagomir

HY-RI03252

*mmu-miR-5107-3p inhibitor*	MicroRNA	Cancer
mmu-miR-5107-3p inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

mmu-miR-5107-3p inhibitor mmu-miR-5107-3p inhibitor

HY-R03253A

*mmu-miR-5107-5p agomir*	MicroRNA	Cancer
mmu-miR-5107-5p agomirs are chemically-modified double-strand miRNA mimics with modified mature miRNA strand: 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 3' end cholesterol group, and full-length nucleotide 2'-methoxy modification. They are designed to mimic endogenous miRNAs and recommended for miRNA functional studies. Compared with miRNA mimics, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.

mmu-miR-5107-5p agomir mmu-miR-5107-5p agomir

Cat. No.	Product Name	Target	Research Area	Image

HY-P991387

AGEN1307 AGEN1327	Transmembrane Glycoprotein	Cancer
AGEN1307 is a human monoclonal antibody (mAb) targeting TIGIT. AGEN1307 has an active FcγR binding region and enhances antibody-dependent cellular cytotoxicity (ADCC). AGEN1307 can be used in cancer research .

Cat. No.	Compare	Product Name	Species	Source	Image

HY-P71493

	Outer membrane protein A/OmpA Protein, E.coli (His-SUMO) 1 Publications Verification ompA; Z1307; ECs1041; Outer membrane protein A; Outer membrane porin A	E.coli	E. coli
	Outer membrane protein A (OmpA) ensures the structural integrity of the bacterial cell wall and cooperates with TolR to stabilize the peptidoglycan layer. As a porin, OmpA controls the permeability of small solutes. Outer membrane protein A/OmpA Protein, E.coli (His-SUMO) is the recombinant E. coli-derived Outer membrane protein A/OmpA protein, expressed by E. coli , with N-SUMO, N-6*His labeled tag.

Compare Products


Products	In-stock - + Add to Cart
Cat. No.
Species
Source
Tag
Accession
Gene ID
Molecular Weight
Purity
Endotoxin Level
Biological Activity
Appearance
Formulation
Storage & Stability
Shipping
Free Sample	Yes No
Size	* This product has been "discontinued". Optimized version of product available: / In-stock - + Add to Cart Get quote

Host:	Mouse (6) Rabbit (1)
Reactivity:	Human (7) Mouse (2) Bovine (1) Rat (2) Zebrafish (1) Chicken (1) Dog (2) Pig (1)
Application:	IHC-P (3) ICC/IF (2) IF-Tissue (1) IP (1) WB (4) FC (1) ELISA (1)
Isotype:	IgG (1) IgG2a (2)
Conjugation:	Non-conjugated (7)
Clonality:	Monoclonal (6) Recombinant (1)
Modification:	Unmodified (6)

Cat. No.	Compare	Product Name	Application	Reactivity	Image

HY-P89131

	CEP72 Antibody (YA8815) FLJ10565; KIAA1519; MGC5307	IHC-P	Human
	CEP72 Antibody (YA8815) is a Mouse-derived and non-conjugated IgG2a monoclonal antibody, targeting to CEP72.

HY-P89131A

	CEP72 Antibody (YA8815)(PBS only) FLJ10565; KIAA1519; MGC5307	IHC-P	Human
	CEP72 Antibody (YA8815) is a Mouse-derived and non-conjugated IgG2a monoclonal antibody, targeting to CEP72.

HY-P85415

	Sarcomeric alpha Actinin Antibody (YA5107) ACTN2; Alpha-actinin-2; Alpha-actinin skeletal muscle isoform 2; F-actin cross-linking protein	WB, ICC/IF	Human, Rat, Bovine, Chicken, Dog, Pig, Zebrafish
	Sarcomeric alpha Actinin Antibody (YA5107) is a Mouse-derived and non-conjugated monoclonal antibody, targeting to Sarcomeric alpha Actinin.

HY-P85438

	Ikaros Antibody (YA5130) IKZF1; IK1; IKAROS; LYF1; ZNFN1A1; DNA-binding protein Ikaros; Ikaros family zinc finger protein 1; Lymphoid transcription factor LyF-1	WB	Human, Mouse, Dog
	Ikaros Antibody (YA5130) is a Mouse-derived and non-conjugated monoclonal antibody, targeting to Ikaros.

HY-P85445

	NSD1 Antibody (YA5137) NSD1; ARA267; KMT3B; Histone-lysine N-methyltransferase; H3 lysine-36 and H4 lysine-20 specific; Androgen receptor coactivator 267 kDa protein; Androgen receptor-associated protein of 267 kDa; H3-K36-HMTase; H4-K20-HMTase; Lysine N-methyltr	WB	Human
	NSD1 Antibody (YA5137) is a Mouse-derived and non-conjugated monoclonal antibody, targeting to NSD1.

HY-P81562

	CD21 Antibody (YA1307) C3DR antibody; CD 21 antibody; CD21 antibody; Complement C3d receptor antibody; Complement component (3d/Epstein Barr virus) receptor 2 antibody; Complement receptor type 2 antibody; CR antibody; Cr2 antibody; CR2_HUMAN antibody; CVID7 antibody; EBV receptor antibody; EBV-R antibody; Epstein Barr virus receptor antibody; Epstein-Barr virus receptor antibody; EVBR antibody; SLEB9 antibody;	WB, IHC-P, ICC/IF, IP, FC, IF-Tissue	Human, Mouse, Rat
	CD21 Antibody (YA1307) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to CD21.

HY-P85615

	FABP3 Antibody (YA5307) 422 protein; Cardiac Fatty Acid Binding Protein; FABP 11; FABP 3; FABP11; FABP3; FABPH_HUMAN; fatty acid binding protein 11; Fatty acid binding protein 3; Fatty acid binding protein 3 muscle and heart; Fatty acid binding protein 3 muscle and heart mammary derived growth inhibitor; Fatty acid binding protein 3 muscle; Fatty acid binding protein 3, muscle and heart; mammary derived growth inhibitor; Fatty acid binding protein 3, muscle; Fatty acid binding protein heart; Fatty acid binding protein, heart; Fatty acid binding protein, muscle and heart	ELISA	Human
	FABP3 Antibody (YA5307) is a Mouse-derived and non-conjugated monoclonal antibody, targeting to FABP3.

Compare Products


Products	In-stock - + Add to Cart
Cat. No.
Host
Reactivity
Application
Dilution Ratio
Molecular Weight
Conjugation
Clonality
Immunogen
Appearance
Isotype
Gene ID
SwissProt ID
Purity
Formulation
Free Sample	Yes No
Size	* This product has been "discontinued". Optimized version of product available: / In-stock - + Add to Cart Get quote

Cat. No.	Product Name		Classification

HY-R03276

*mmu-miR-5130* mimic**		MicroRNAs miRNA mimics
mmu-miR-5130 mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.

HY-R00240

*hsa-miR-1307-5p mimic*		MicroRNAs miRNA mimics
hsa-miR-1307-5p mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.

HY-R03252

*mmu-miR-5107-3p mimic*		MicroRNAs miRNA mimics
mmu-miR-5107-3p mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.

HY-R00239

*hsa-miR-1307-3p mimic*		MicroRNAs miRNA mimics
hsa-miR-1307-3p mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.

HY-RI00239A

*hsa-miR-1307-3p antagomir*		MicroRNAs miRNA antagomirs
hsa-miR-1307-3p antagomirs are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA antagomirs have 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 1 cholesterol group at the 3' end, and full-length nucleotide 2'-methoxy modification. The miRNA antagomirs strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning. Stability of miRNA antagomirs appears to be significantly higher than miRNA inhibitors, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.

HY-R03253

*mmu-miR-5107-5p mimic*		MicroRNAs miRNA mimics
mmu-miR-5107-5p mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.

HY-RI03276A

*mmu-miR-5130* antagomir**		MicroRNAs miRNA antagomirs
mmu-miR-5130 antagomirs are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA antagomirs have 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 1 cholesterol group at the 3' end, and full-length nucleotide 2'-methoxy modification. The miRNA antagomirs strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning. Stability of miRNA antagomirs appears to be significantly higher than miRNA inhibitors, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.

HY-RI03276

*mmu-miR-5130* inhibitor**		MicroRNAs miRNA inhibitors
mmu-miR-5130 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

HY-R03276A

*mmu-miR-5130* agomir**		MicroRNAs miRNA agomirs
mmu-miR-5130 agomirs are chemically-modified double-strand miRNA mimics with modified mature miRNA strand: 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 3' end cholesterol group, and full-length nucleotide 2'-methoxy modification. They are designed to mimic endogenous miRNAs and recommended for miRNA functional studies. Compared with miRNA mimics, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.

HY-RI00240

*hsa-miR-1307-5p inhibitor*		MicroRNAs miRNA inhibitors
hsa-miR-1307-5p inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

HY-R00240A

*hsa-miR-1307-5p agomir*		MicroRNAs miRNA agomirs
hsa-miR-1307-5p agomirs are chemically-modified double-strand miRNA mimics with modified mature miRNA strand: 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 3' end cholesterol group, and full-length nucleotide 2'-methoxy modification. They are designed to mimic endogenous miRNAs and recommended for miRNA functional studies. Compared with miRNA mimics, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.

HY-RI00240A

*hsa-miR-1307-5p antagomir*		MicroRNAs miRNA antagomirs
hsa-miR-1307-5p antagomirs are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA antagomirs have 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 1 cholesterol group at the 3' end, and full-length nucleotide 2'-methoxy modification. The miRNA antagomirs strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning. Stability of miRNA antagomirs appears to be significantly higher than miRNA inhibitors, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.

HY-RI03253A

*mmu-miR-5107-5p antagomir*		MicroRNAs miRNA antagomirs
mmu-miR-5107-5p antagomirs are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA antagomirs have 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 1 cholesterol group at the 3' end, and full-length nucleotide 2'-methoxy modification. The miRNA antagomirs strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning. Stability of miRNA antagomirs appears to be significantly higher than miRNA inhibitors, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.

HY-R03252A

*mmu-miR-5107-3p agomir*		MicroRNAs miRNA agomirs
mmu-miR-5107-3p agomirs are chemically-modified double-strand miRNA mimics with modified mature miRNA strand: 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 3' end cholesterol group, and full-length nucleotide 2'-methoxy modification. They are designed to mimic endogenous miRNAs and recommended for miRNA functional studies. Compared with miRNA mimics, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.

HY-RI00239

*hsa-miR-1307-3p inhibitor*		MicroRNAs miRNA inhibitors
hsa-miR-1307-3p inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

HY-R00239A

*hsa-miR-1307-3p agomir*		MicroRNAs miRNA agomirs
hsa-miR-1307-3p agomirs are chemically-modified double-strand miRNA mimics with modified mature miRNA strand: 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 3' end cholesterol group, and full-length nucleotide 2'-methoxy modification. They are designed to mimic endogenous miRNAs and recommended for miRNA functional studies. Compared with miRNA mimics, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.

HY-RI03253

*mmu-miR-5107-5p inhibitor*		MicroRNAs miRNA inhibitors
mmu-miR-5107-5p inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

HY-RI03252A

*mmu-miR-5107-3p antagomir*		MicroRNAs miRNA antagomirs
mmu-miR-5107-3p antagomirs are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA antagomirs have 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 1 cholesterol group at the 3' end, and full-length nucleotide 2'-methoxy modification. The miRNA antagomirs strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning. Stability of miRNA antagomirs appears to be significantly higher than miRNA inhibitors, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.

HY-RI03252

*mmu-miR-5107-3p inhibitor*		MicroRNAs miRNA inhibitors
mmu-miR-5107-3p inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

HY-R03253A

*mmu-miR-5107-5p agomir*		MicroRNAs miRNA agomirs
mmu-miR-5107-5p agomirs are chemically-modified double-strand miRNA mimics with modified mature miRNA strand: 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 3' end cholesterol group, and full-length nucleotide 2'-methoxy modification. They are designed to mimic endogenous miRNAs and recommended for miRNA functional studies. Compared with miRNA mimics, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.

Inquiry Online

Submit your filled information, we will contact you soon.

Salutation:		* Country or Region:
* Applicant Name:		* Organization Name:
* Department:
* Email Address:		* Product Name:
Cat. No.:		* Requested quantity:
* Phone Number:
MCE Japan Authorized Agent:	ナミキ商事株式会社コスモ・バイオ株式会社重松貿易株式会社
Remarks:

Inquiry Online

Your information is safe with us. * Required Fields.

MCE Japan Authorized Agent ナミキ商事株式会社コスモ・バイオ株式会社重松貿易株式会社
Salutation			Country or Region *
Applicant Name *			Organization Name *
Department *
Email Address *			Product Name *
Cat. No.			Requested quantity *
Phone Number *
Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: